FDA Advisory Board recommends approval of J & J vaccine

Experts are encouraging everyone to receive Johnson & JohnsonCOVID Vaccine for Obtaining Booster Shots After Food and Drug Administration (FDAThe Advisory Board unanimously voted to recommend a second dose to all persons over the age of 18.

An advisory board of public health experts announced on Friday that all adults vaccinated with a single vaccination will receive a second vaccination at least two months after the first vaccination.

A study published Thursday but not peer-reviewed tracked more than 620,000 veterans who were vaccinated and found that protection dropped from 88% in March to just 3% in August. bottom.

“There are public health obligations here, because this is a group that is generally less effective than we’ve seen with mRNA vaccines,” said Dr. Arnoldmont, acting chairman of the committee and professor of epidemiology. University Michigan The Faculty of Public Health said.

“So there is some urgency there to do something.”

The Food and Drug Administration Advisory Board recommended that all adults be advised to receive booster shots of the Johnson & Johnson COVID vaccine.

Nearly 15 million Americans received the J & J vaccine First approved in February

Following the unanimous vote of the FDA Advisory Board, the FDA must now make a decision, but is expected to follow the Commission’s proposal.

By comparison, Moderna’s vaccine efficacy was reduced from 92% to 64%, and Pfizer’s vaccine protection was reduced from 91% to 50%.

According to the Centers for Disease Control and Prevention (CDC), nearly 15 million Americans have been vaccinated with the J & J vaccine, of which nearly 91% have been vaccinated more than two months ago.

COVID vaccine booster shots are recommended, despite a decrease in cases of infectious diseases after the summer surge due to the delta mutation. Experts point out CDC data showing that unvaccinated adults are 11 times more likely to die of COVID than vaccinated adults.

“J & J is a very good vaccine, and I think it’s probably a two-shot vaccine,” said Dr. Ashish Jha, Dean of the Faculty of Public Health at Brown University. CNN.. “It’s really urgent for people to get that second shot pretty quickly.

On Thursday, the FDA Advisory Board recommended Moderna booster shots for people over the age of 65, but the FDA postponed the decision to authorize the COVID vaccine for teenagers and young adults.

The FDA will review the recommendations of the Advisory Board on J & J and Moderna COVID Booster Shots to make official decisions. If the FDA accepts the recommendation, it’s expected and booster shots may be available soon next week.

The FDA previously allowed booster shots of the Pfizer COVID vaccine to people over the age of 65, or adults who are considered “high risk” because of their livelihood, work, or health status.

COVID booster shots are recommended as delta variants continue to spread

According to data from Johns Hopkins University, more than 353,000 coronavirus deaths have been reported this year, more than the 352,000 recorded in 2020.

Recent CDC data show that unvaccinated adults are 11 times more likely to die of COVID than vaccinated adults.

“I think anyone who gets a single Johnson & Johnson vaccine can benefit from two Johnson & Johnson vaccines,” said the FDA’s vaccines and related biological products. Dr. Paul Ofit, a member of the advisory board, told CNN.

He believes that if the J & J vaccine had not been produced in such an emergency, it would have been initially recommended as a double dose vaccine.

A study of military veterans concluded that: We are facing an increased risk of infection with delta variants.

The FDA Advisory Board also discussed the possibility of mixing and matching booster shots. This gives them flexibility and may improve their immunity with a single dose of J & J.

However, due to the limited data on this issue, some were skeptical about the combination of vaccines.

FDA Advisory Board recommends approval of J & J vaccine

Source link FDA Advisory Board recommends approval of J & J vaccine

Exit mobile version